Instructions
Page 1 notes that preferred products used in accordance with FDA labeling may not need prior authorization, and points to the NYRx Preferred Drug List. Fill out every section completely and legibly. Before using this form, check whether the drug has its own NYRx request form or worksheet, such as those for CNS stimulants, opioids or growth hormone, since the standardized form is for drugs without one.
Member Information
Enter the member's last and first name and the Medicaid ID in its printed format of two letters, five numbers and one letter. Add date of birth as MM/DD/YYYY, sex (Male, Female or X), height, weight and allergies. Answer whether the member is transitioning from a facility, and if yes, name the facility. The member's last name and date of birth repeat at the top of pages 2 to 4.
Prescriber Information
Give the prescriber's name, NPI, specialty, street address, phone and fax. The fax number matters because NYRx sends its decision back to it. If an authorized agent submits, enter the agent's name; the form defines an authorized agent as an employee of the prescriber who has access to the member's medical records, and it rejects requests submitted by third parties.
Medication and Dispensing Information
List drug name, strength, formulation, dosing frequency, quantity and day supply, then select the route of administration. For physician-administered medication, say whether this provider will order and administer it, or name the administering provider. Choose new therapy, renewal of therapy previously covered by NYRx (same dose, or a new strength or frequency with the prior dose), or continuation from another insurer, with approximate start dates.
Clinical Criteria, questions 1 to 3
Question 1 asks for up to two diagnoses with ICD-10 codes. Question 2 asks whether the drug is used for an FDA-approved or official compendia indication (AHFS DI or DRUGDEX); if not, attach supporting literature for the off-label use. Question 3 asks whether the drug needs dose titration across multiple strengths or doses per day, and if so, for the titration schedule.
Clinical Criteria, questions 4 and 5
Question 4 applies to non-preferred agents: state whether you are willing to prescribe a preferred agent from the Preferred Drug List and, if not, the clinical reason the member cannot use one in the same class. Question 5 records treatment failure, adverse reaction or allergy with a preferred drug, with space for two prior therapies, their dosage, start and stop dates, and what happened.
Clinical Criteria, questions 6 and 7
Question 6 asks whether there is a documented history of successful therapeutic control with the non-preferred drug and whether transition to a preferred drug is medically contraindicated, with space to explain. Question 7 asks whether relevant lab results, tests and diagnostic studies supporting the therapy are attached. These answers carry the case for non-preferred drugs, which need treatment failure, adverse reaction or documented stable control.
Attestation and fax submission
Page 4 states that submitting the form confirms the information is accurate and true and that supporting documentation is available for review on request of the New York State Department of Health or CMS. It warns of civil penalties and treble damages under the federal and New York False Claims Acts for false material records. Fax the completed form to the NYRx Clinical Call Center.